Skip to main content
  • Richard Boucher-new-mask-newsweek-article

    Boucher Tells Good Morning America the Nose Is Fertile Ground For Infection

    Richard Boucher, MD Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine in the division of pulmonary diseases and critical care medicine was interviewed by ABC Good Morning America in a story that warns people about wearing masks that expose the nose. The story recognized Boucher’s research that mapped locations in the respiratory tract to see where COVID-19 mo … Read more

  • Richard Boucher-new-mask-newsweek-article

    NIH Features Boucher in the Story of Mucus

    Richard Boucher, MD In “Marvels of Mucus and Phlegm: The Slime that Keeps You Healthy,” the NIH featured Richard Boucher, MD, to help explain why mucus gets a bad rap and what its true purpose is in human health. Boucher, the James Moeser Eminent Distinguished Professor of Medicine and director of the UNC Marsico Lung Institute, has been studying the ins and outs of mucus and its … Read more

  • shannon-carson

    Carson Contributes to Wall Street Journal Article, the $1.9 Million Covid Patient

    Shannon Carson, MD A Wall Street Journal article considered how lengthy hospital stays impact the need for expansions, which require more doctors and nurses and more technology to monitor patients and protect staff. This also puts a significant strain on the budgets of public and private health insurers and households “Critical care is one of the most costly services a hospital p … Read more

  • July- Grants and Funding

    Department of Medicine Grants & Funding: July 1 – July 31, 2020

    Division of Geriatric Medicine Joshua Niznik, PharmD, PhD, was awarded pilot funding from the US Deprescribing Research Network (USDeN) for his proposal entitled “Deprescribing Bisphosphonates in Nursing Home Residents with Dementia.” Division of Hematology Stephan Moll, MD, received an award from the Anticoagulation Forum for “2020 Clinical Fellowship Award in General Vascular M … Read more

  • ashley-henderson

    Henderson Featured in Carolina Highlight

    Ashley Henderson, MD Ashley Glyn Henderson, MD, associate professor of medicine in the division of pulmonary and critical care medicine was featured in a Carolina Highlight this week. Here’s what one of Henderson’s patients had to say: “Dr. Henderson is the best! She is caring, professional, compassionate, concerned about all of my concerns and questions, considers all my input a … Read more

  • Patricia Rivera, MD

    Rivera Receives $1.5 Million Grant For Lung Cancer Screening Study

    M. Patricia Rivera, MD, ATSF M. Patricia Rivera, MD, ATSF, professor of medicine in the division of pulmonary and critical care medicine, has received a four year, $1.5 million NIH R01 grant to study “Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening” with Louise Henderson, PhD, in the department of radiology. The investigators will evaluate the e … Read more

  • Subhashini Sellers, MD

    Sellers Receives Pilot Funding To Study Upper Respiratory Immune Response in COVID-19

    Subhashini Sellers, MD Subhashini Sellers, MD, MSc, assistant professor in the division of pulmonary and critical care medicine, has received pilot funding from the UNC Center for Environmental Health Sciences to study the upper respiratory immune response in COVID-19. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and resulting Coronavirus disease 2019 (COVID-19) r … Read more

  • Richard Boucher-new-mask-newsweek-article

    Boucher Comments On the Quest For a COVID-19 Cure

    Richard Boucher, MD Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine, in the division of pulmonary diseases and critical care medicine, and director of the Marsico Lung Institute, explained to Gulf Today why he believes some repurposed drugs currently under consideration to treat COVID-19 patients could work. “The lung only fails in so many different ways, a … Read more

  • Richard Boucher-new-mask-newsweek-article

    Boucher Discusses Coronavirus Treatments With News & Observer

    Richard Boucher, MD While there is hope that a “sophisticated new drug treatment to prevent people from getting severely ill from COVID-19” will be available in the fall, experts says treatments most likely to be available with be repurposed therapeutic drugs meant to treat late-stage symptoms. Richard Boucher, MD, the James C. Moeser Eminent Professor of Medicine, Division of Pu … Read more

  • From H1N1 to COVID-19, Vigeland’s Career Focuses on Helping the Sickest

    Christine Vigeland, MD Christine Vigeland, MD, found her calling during residency as the H1N1 pandemic was ending in 2010. She dedicated her career to researching acute respiratory distress syndrome (ARDS) and treating ICU patients. Ten years later, the knowledge she’s gained and her continued commitment to the most critical patients are guiding her through another pandemic. “I d … Read more

  • June- Grants and Funding

    Department of Medicine Grants & Funding: June 1 – June 30, 2020

    Division of Cardiology Anil Gehi, MD, received a grant from the Bristol-Myers Squibb Foundation to create a new patient education program to help patients with atrial fibrillation during the COVID-19 pandemic. Division of Hematology Dougald Monroe, PhD, received NIH funding to help guide the development of novel treatments and new therapeutics for bleeding. Nigel Mackman, PhD, an … Read more

  • Hagan Receives ATS Junior Investigator Award

    Robert Hagan, MD, PhD Robert Hagan, MD, PhD, instructor in the division of pulmonary diseases and critical care medicine, has received a Junior Investigator Award from the American Thoracic Society’s Journal of Respiratory Cell and Molecular Biology. The prestigious award recognizes Hagan’s research on innate immunity in respiratory infections and lung injury and his paper Myeloi … Read more